ARCHIVES

DCT Faces Hard Choices, Clinical Group Need Re-Examination, Chabner tells BSC

This article is from The Cancer Letter archive.

Vol. 08 No. 44 | November 12, 1982

Download PDF Visit The Full Archive

Related Articles

Deluge Of SBIR Contract Proposals Changes Picture at NCI, Could Save $5 Million For Cancer

April 12, 1985

NCI Closes Iressa Trial For NSCLC When Data Indicate No Survival Benefit

April 29, 2005

Greatest Need Of Cancer Care Givers: “Will to Work Together,” ACCC President Anderson Says

August 15, 1986

Interferon Alpha-2B Effective For Malignant Melanoma

July 27, 2001

BMS, ImClone To Develop New Drug IMC-C225, Targets EGF Receptor.

September 28, 2001

DCT Board Approves Concepts For New RFA, New And Recompeting Contracts

June 18, 1982